Danang Cerebral Venous Thrombosis Registry
Official title: A Prospective Registry of Patients With Cerebral Venous Thrombosis at Da Nang Hospital: Clinical Characteristics, Imaging Manifestations, and Functional Outcomes
Run by Da Nang Hospital · NCT07890675 · Data updated 2026-11-12
This registry collects information on adults with cerebral venous thrombosis admitted to Danang Hospital to see how the condition presents, what imaging shows, risk factors, and how patients recover.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Da Nang Hospital Academic / other |
| Locations | 1 site (Da Nang, Da Nang) |
| Status | Recruiting |
| Started | October 9, 2025 |
| Main results expected | October 9, 2028 |
| Study ends | July 1, 2029 |
| Registry record updated | October 26, 2026 |
| Trial ID | NCT07890675 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with definite CVT diagnosed by radiologic imaging and admitted to Danang Hospital, with consent and willingness to participate in follow-up.
✕Probably not a fit
Patients without CVT or those unable to complete follow-up may not benefit from the registry data.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, prospective registry of adults with cerebral venous thrombosis at Da Nang Hospital. It collects standardized data on demographics, risk factors, clinical presentation, lab results, and neuroimaging findings (CTV/MRV) and tracks treatment and short-term outcomes during hospitalization and at follow-up. The study aims to describe the clinical spectrum, imaging patterns, etiologies, and functional recovery in this Vietnamese population. Standard anticoagulant therapy is used for management, and inclusion requires confirmed CVT and informed consent. Data will be analyzed to identify patterns and potential prognostic indicators in this setting.
Why it matters
Potential benefit: Understanding real-world CVT in central Vietnam could improve diagnosis and management, potentially improving outcomes for future patients.
How similar studies have gone: Observational CVT registries in other settings have provided valuable insights into presentation and outcomes, supporting the value of this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18 years or older. 2. Definite diagnosis of cerebral venous thrombosis (CVT) confirmed by neuroimaging, including computed tomography venography (CTV), magnetic resonance venography (MRV), or digital subtraction angiography (DSA). 3. Admitted to Danang Hospital for acute or subacute management. 4. Patient or legally authorized representative provides written informed consent to participate in the registry. Exclusion Criteria: 1. Non-thrombotic occlusion of cerebral veins or sinuses (e.g., direct tumor invasion, vascular malformation, or extrinsic mechanical compression without thrombosis). 2. Pre-existing advanced terminal illness or severe co-morbid condition with a life expectancy of less than 6 months prior to CVT presentation (e.g., end-stage malignancy, advanced organ failure). 3. pre-stroke modified Rankin Scale (mRS) score ≥ 2 4. Inability or refusal of the patient or their legal representative to complete the 6-month follow-up assessment. 5. Refusal to provide informed consent.
Where it's running
-
Da Nang Hospital
Da Nang, Da Nang, Vietnam Recruiting
Study contacts
- Principal investigator: Son V. D. Nguyen, MD, MSc — Da Nang Hospital
- Study coordinator: Son V. D. Nguyen, MD, MSc
- Email: dangsonnguyen1892@gmail.com
- Phone: +84 934995168
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Remote Ischaemic Conditioning for Fatigue After Stroke 2
Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.
-
Dual-task balance training plus computer-based cognitive training after stroke
In adults who recently had a stroke, the study tests whether adding computerized cognitive exercises to balance training improves balance and other recovery outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.